OpenAI Quietly Ships GPT-6 Rosalind for Drug Discovery Behind Trusted-Access Gates; Indian Pharma Can Apply, Indian Academic Labs Cannot Yet

OpenAI has released GPT-6 Rosalind, a frontier biology and drug-discovery model on GPT-6 Astra’s weights, only to vetted research organisations at premium prices. It is rated High risk for biology. Indian pharma companies can apply, but the free academic plan covers only US university labs.